Welcome to our dedicated page for ALIGN TECHNOLOGY SEC filings (Ticker: ALGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Align Technology filings document the regulatory record for a medical device company built around Invisalign clear aligners, iTero intraoral scanners, exocad CAD/CAM software and digital dentistry workflows. Its 8-K filings report operating and financial results, capital-structure actions, material events and governance changes, including bylaw amendments and executive compensation-related matters.
Proxy materials describe board structure, independence, risk oversight, shareholder voting items, executive compensation and governance policies. The filing record also captures shareholder meeting matters, stockholder rights provisions, common-stock disclosures and risk topics tied to Align's global clear-aligner, imaging systems and CAD/CAM services businesses.
Align Technology, Inc. furnished an update saying it has issued a press release and will hold a conference call covering its financial results for the fourth quarter and full fiscal year ended December 31, 2025. The press release is provided as Exhibit 99.1 and is treated as furnished, not filed, under securities law.
BlackRock, Inc. reports beneficial ownership of 4,113,442 shares of Align Technology common stock, representing 5.7% of the outstanding class as of 12/31/2025. BlackRock has sole voting power over 3,858,169 shares and sole dispositive power over 4,113,442 shares, with no shared voting or dispositive power.
The filing states that these securities are held by certain BlackRock business units in the ordinary course of business and not for the purpose of changing or influencing control of Align Technology. Various underlying persons have rights to dividends or sale proceeds, but no single person has an interest in more than five percent of Align Technology’s common shares.
Align Technology (ALGN) reported Q3 results with net revenues of $995.7 million and net income of $56.8 million. Diluted EPS was $0.78 versus $1.55 a year ago as costs rose and one‑time items weighed on results.
Gross profit was $639.2 million on cost of net revenues of $356.5 million. Operating expenses were $542.9 million, including $31.8 million of restructuring and other charges. The quarter also included a $23.1 million impairment on assets held for sale and a $14.9 million inventory impairment. Effective tax rate was 40.1%.
By segment, Clear Aligner revenue was $805.8 million and Systems & Services was $189.9 million. Geographically, revenue was $410.6 million in the U.S., $210.8 million in Switzerland, and $374.3 million in other international markets.
Cash and cash equivalents were $1.00 billion, deferred revenues totaled $1.38 billion, and shares outstanding were 71,749,995 as of October 29, 2025. Year‑to‑date, the company repurchased $371.6 million of stock and has $928.4 million remaining under the April 2025 authorization. Align paid $31.75 million into escrow for a preliminarily approved settlement.
Align Technology furnished an 8-K under Item 2.02 announcing it issued a press release and will hold a conference call regarding its financial results for the third quarter ended September 30, 2025. The press release is included as Exhibit 99.1, and a Cover Page Interactive Data File is embedded as Exhibit 104. The company notes this information is being furnished, not filed, under the Exchange Act.
Align Technology, Inc. disclosed that it has terminated the employment of Mr. Stuart Hockridge, its Executive Vice President, Global Human Resources, with the termination effective in May 2026. The company states that the termination is not for “cause” under his May 23, 2016 employment agreement. Any severance, compensation, or benefits he receives will be materially consistent with that agreement and with the disclosures under “Termination Unrelated to a Change of Control” in Align’s 2025 proxy statement filed on April 8, 2025.
Align Technology (ALGN) Q2 2025 10-Q highlights:
- Revenue: $1.01 bn, -1.6% YoY; Clear Aligner -3.3%, Systems & Services +5.6%.
- Margin: Gross margin 70.0% (70.2% LY); operating margin 16.1% vs 14.3% on lower legal costs.
- Earnings: Net income $124.6 m (+29%), diluted EPS $1.72 (+34%). Six-month EPS $2.98 (+11%).
- Cash & Liquidity: Cash & equivalents $901 m (-14% YTD); no debt; operating cash flow $181 m (-4%).
- Capital return: Completed $1 bn Jan-23 buyback; repurchased 1.34 m shares for $225 m in H1; new $1 bn Apr-25 program with $200 m OMR slated for H2.
- Share count: 72.5 m outstanding (-3.5% YoY).
- Legal/one-offs: Recorded $4.2 m additional accrual toward $31.75 m Section-1 antitrust settlement (prelim approval 5/28/25); VAT dispute with UK HMRC refunded ~$100 m but subject to appeal.
- Segment profit: Clear Aligner op-profit $267 m (-11%); Systems & Services $86 m (+21%).
- Balance sheet: Inventories $243.8 m (-4% YTD); goodwill now $491 m after Cubicure acquisition.
- Tax: Effective rate 28.2% vs 32.9%.
Key takeaways: Despite modest top-line contraction, disciplined expense control, share buybacks and favorable other income drove double-digit EPS growth. Cash burn and continuing legal/tax uncertainties temper outlook, but new $1 bn authorization reinforces management’s confidence.